Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheng Bin

Showing results (191-200 of 206) with videos related to

Pageof 21
Sort By:
Plos One|May 31, 2014
Identification of druggable cancer driver genes amplified across TCGA datasetsYing Chen, Jeremy McGee, Xianming Chen, et al.
Cancer Discovery|January 7, 2016
Oncogenic BRAF Deletions That Function as Homodimers and Are Sensitive to Inhibition by RAF Dimer Inhibitor LY3009120Shih-Hsun Chen, Youyan Zhang, Robert D Van Horn, et al.
Cell Biology International|August 30, 2008
Adenoviral-mediated interleukin-18 expression in mesenchymal stem cells effectively suppresses the growth of glioma in ratsGang Xu, Xiao-Dan Jiang, Ying Xu, et al.
Nature|December 18, 2012
Suppression of neuroinflammation by astrocytic dopamine D2 receptors via αB-crystallinWei Shao, Shu-zhen Zhang, Mi Tang, et al.
The Journal of Biological Chemistry|June 3, 2004
Novel lipoglycopeptides as inhibitors of bacterial signal peptidase IPalaniappan Kulanthaivel, Adam J Kreuzman, Mark A Strege, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2017
Mouse PDX Trial Suggests Synergy of Concurrent Inhibition of RAF and EGFR in Colorectal Cancer with <i>BRAF</i> or <i>KRAS</i> MutationsYung-Mae M Yao, Gregory P Donoho, Philip W Iversen, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 11, 2020
Tumor regression and resistance mechanisms upon CDK4 and RAF1 inactivation in KRAS/P53 mutant lung adenocarcinomasLaura Esteban-Burgos, Haiyun Wang, Patricia Nieto, et al.
Scientific Reports|July 3, 2020
Molecular dissection of CRC primary tumors and their matched liver metastases reveals critical role of immune microenvironment, EMT and angiogenesis in cancer metastasisJiangang Liu, Yong Beom Cho, Hye Kyung Hong, et al.
BMC Infectious Diseases|August 12, 2018
Vaccination demonstration zone successfully controls rabies in Guangxi Province, ChinaXian-Kai Wei, Yi Xiong, Xiao-Ning Li, et al.
Molecular Cancer Therapeutics|October 25, 2019
A Phase I Study of LY3009120, a Pan-RAF Inhibitor, in Patients with Advanced or Metastatic CancerRyan J Sullivan, Antoine Hollebecque, Keith T Flaherty, et al.
Pageof 21

Showing results (191-200 of 206) with videos related to

Sort By:
Pageof 21
Plos One|May 31, 2014
Identification of druggable cancer driver genes amplified across TCGA datasetsYing Chen, Jeremy McGee, Xianming Chen, et al.
Cancer Discovery|January 7, 2016
Oncogenic BRAF Deletions That Function as Homodimers and Are Sensitive to Inhibition by RAF Dimer Inhibitor LY3009120Shih-Hsun Chen, Youyan Zhang, Robert D Van Horn, et al.
Cell Biology International|August 30, 2008
Adenoviral-mediated interleukin-18 expression in mesenchymal stem cells effectively suppresses the growth of glioma in ratsGang Xu, Xiao-Dan Jiang, Ying Xu, et al.
Nature|December 18, 2012
Suppression of neuroinflammation by astrocytic dopamine D2 receptors via αB-crystallinWei Shao, Shu-zhen Zhang, Mi Tang, et al.
The Journal of Biological Chemistry|June 3, 2004
Novel lipoglycopeptides as inhibitors of bacterial signal peptidase IPalaniappan Kulanthaivel, Adam J Kreuzman, Mark A Strege, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2017
Mouse PDX Trial Suggests Synergy of Concurrent Inhibition of RAF and EGFR in Colorectal Cancer with <i>BRAF</i> or <i>KRAS</i> MutationsYung-Mae M Yao, Gregory P Donoho, Philip W Iversen, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 11, 2020
Tumor regression and resistance mechanisms upon CDK4 and RAF1 inactivation in KRAS/P53 mutant lung adenocarcinomasLaura Esteban-Burgos, Haiyun Wang, Patricia Nieto, et al.
Scientific Reports|July 3, 2020
Molecular dissection of CRC primary tumors and their matched liver metastases reveals critical role of immune microenvironment, EMT and angiogenesis in cancer metastasisJiangang Liu, Yong Beom Cho, Hye Kyung Hong, et al.
BMC Infectious Diseases|August 12, 2018
Vaccination demonstration zone successfully controls rabies in Guangxi Province, ChinaXian-Kai Wei, Yi Xiong, Xiao-Ning Li, et al.
Molecular Cancer Therapeutics|October 25, 2019
A Phase I Study of LY3009120, a Pan-RAF Inhibitor, in Patients with Advanced or Metastatic CancerRyan J Sullivan, Antoine Hollebecque, Keith T Flaherty, et al.
Pageof 21